Elevated soluble urokinase plasminogen activator receptor serum levels indicate poor survival following transarterial chemoembolization therapy for hepatic malignancies: An exploratory analysis

BACKGROUND AND AIM: Transarterial chemoembolization (TACE) represents a standard of care for patients with intermediate‐stage hepatocellular carcinoma (HCC) or liver metastases. However, identification of the ideal candidates for TACE therapy remains challenging. The soluble urokinase plasminogen ac...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :JGH Open
Главные авторы: Loosen, Sven H, Schulze‐Hagen, Max, Vucur, Mihael, Gorgulho, Joao, Paffenholz, Pia, Benz, Fabian, Mohr, Raphael, Demir, Münevver, Wree, Alexander, Kuhl, Christiane, Trautwein, Christian, Tacke, Frank, Bruners, Philipp, Luedde, Tom, Roderburg, Christoph
Формат: Artigo
Язык:Inglês
Опубликовано: Wiley Publishing Asia Pty Ltd 2021
Предметы:
Original Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7936623/
https://ncbi.nlm.nih.gov/pubmed/33732882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jgh3.12501
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы